Anebulo Pharmaceuticals (ANEB) EPS (Basic) (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) posted quarterly EPS (Basic) of -$0.06 for Q4 2025, up 36.49% year-over-year from -$0.05 in Q4 2024, and up 29.62% quarter-over-quarter from -$0.09 in Q3 2025.
Anebulo Pharmaceuticals (ANEB) EPS (Basic) (2020 - 2025) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported EPS (Basic) for 6 consecutive years, with -$0.06 the latest figure, recorded in Q4 2025.
- In Q4 2025, EPS (Basic) rose 36.49% year-over-year to -$0.06; the TTM figure through Dec 2025 stood at -$0.25 (up 18.05% YoY), while the FY2025 annual figure was -$0.28, up 13.43% from the prior year.
- EPS (Basic) climbed to -$0.06 in Q4 2025 per ANEB's latest filing, from -$0.09 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.05 in Q1 2025 and bottomed at -$2.14 in Q2 2021.
- Historically, EPS (Basic) has averaged -$0.24 across 5 years, with a median of -$0.1 in 2022.
- Annual changes were most pronounced in 2021 — EPS (Basic) slumped 487.02% — and 2022, when it jumped 95.35%.
- Anebulo Pharmaceuticals' EPS (Basic) stood at -$0.15 in 2021, then decreased by 3.49% to -$0.15 in 2022, then advanced by 28.83% to -$0.11 in 2023, then climbed by 10.64% to -$0.1 in 2024, then soared by 36.49% to -$0.06 in 2025.
- Business Quant data shows ANEB's EPS (Basic) at -$0.06 in Q4 2025, -$0.09 in Q3 2025, and -$0.07 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - | -0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.06 |
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | -0.07 |
| Mar 31, 2025 | -0.05 |
| Dec 31, 2024 | -0.10 |
| Sep 30, 2024 | -0.10 |
| Jun 30, 2024 | -0.05 |
| Mar 31, 2024 | -0.08 |
| Dec 31, 2023 | -0.11 |
| Sep 30, 2023 | -0.12 |
| Jun 30, 2023 | -0.29 |
| Mar 31, 2023 | -0.12 |
| Dec 31, 2022 | -0.15 |
| Sep 30, 2022 | -0.13 |
| Jun 30, 2022 | -0.10 |
| Mar 31, 2022 | -0.08 |
| Dec 31, 2021 | -0.15 |
| Sep 30, 2021 | -0.07 |
| Jun 30, 2021 | -2.14 |
| Mar 31, 2021 | -0.68 |